AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Hmpgloballearningnetwork

Published November 12, 2026

HHS Announces Funding for Ibogaine and Rapid-Acting Psychotropic Research

Read the full story at Hmpgloballearningnetwork

Psychedelics Update. HHS Announces Funding for Ibogaine and Rapid-Acting ... Psychedelics Academy banner. US Department of Health and Human.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics